Address	4/F, Korea Bio Park Bldg. B Seongnam-si GY 13488 Korea, Republic Of
Employees	-
Website	http://www.genexine.com
Updated	09/14/2018
Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. It operates through the following business divisions: Novel drug development and Cell culture media manufacturing. The company was founded by Young Chul Sung on June 8, 1999 and is headquartered in Seongnam, South Korea.